Terms ending in 2036
Every in-force patent on Aarhus Universitet's record whose computed term ends in 2036, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,400,288 | Microrna-Based Method for Early Detection of Prostate Cancer in Urine Samples In force · High confidence | Qiagen GmbH | In force | High confidence | |
| US 10,358,681 | A Microrna-Based Method for Assessing the Prognosis of a Prostate Cancer Patient In force · High confidence | Qiagen GmbH | In force | High confidence | |
| US 10,647,749 | Glycosylated Yghj Polypeptides from Enterotoxigenic Escherichia Coli (ETEC) In force · High confidence | Syddansk Universitet | In force | High confidence | |
| US 11,655,274 | Glycosylated Yghj Polypeptides from Enterotoxigenic Escherichia Coli (ETEC) In force · Medium confidence | Aarhus Universitet | In force | Medium confidence | |
| US 12,023,322 | Rufinamide for Use in the Treatment of Myotonia In force · High confidence | Aarhus Universitet | In force | High confidence | |
| US 12,533,345 | Rufinamide for Use in the Treatment of Myotonia In force · High confidence | Aarhus Universitet | In force | High confidence |
6 of 6 patents shown. Soonest term end first, then patent number.
3 of these are in force and held by Aarhus Universitet.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.